Clinical resistance of Trichomonas vaginalis to metronidazole is best correlated with MIC values measured under aerobic conditions. Under these conditions both disulfiram (bis(diethylthiocarbamoyl)disulphide), and its first mammalian metabolite, ditiocarb (diethyldithiocarbamate), showed high levels of activity against metronidazole-sensitive (disulfiram MIC, 0.1-0.7 M; ditiocarb MIC, 0.3-9 M) and -resistant (MICs 0.2-1.3 M and 1.2-9 M respectively) isolates. Tritrichomonas foetus was also sensitive-the MICs for seven metronidazole-sensitive isolates were 0.1-1.0 M for disulfiram and 1.0-6.9 M for ditiocarb; those for two highly metronidazole-resistant strains were 0.3-1.3 M and 0.6-6 M respectively. Under anerobic conditions most strains became highly resistant to both compounds. Surprisingly, disulfiram was consistently more active than ditiocarb.
Introduction
Trichomonas vaginalis is the causative agent of human trichomoniasis, probably the commonest non-viral sexuallytransmitted disease with about 170 million new infections each year. 1 The standard and usually effective treatment is with metronidazole or one of the other 5-nitroimidazoles; however, intractable infections with metronidazoleresistant strains of T. vaginalis are well characterized. Providing appropriate assay conditions are employed, there is a reasonable correlation between resistance detected in vitro and treatment outcome. 2 Although higher doses are often effective, no other safe and effective therapy for metronidazole-resistant trichomoniasis is currently available.
Tritrichomonas foetus is sexually transmitted and causes economic losses by inducing cows to abort. Although vaccines are available, control of bovine trichomoniasis is difficult, not least because of the lack of an approved chemotherapeutic agent. In particular, 5-nitroimidazoles are no longer permitted for animals intended for human consumption in either the USA or the European Union.
Disulfiram (bis(diethylthiocarbamoyl)disulphide, Antabuse) has been in clinical use for many years as an aid to the treatment of alcoholism; it has also been shown to have in-vitro activity against a number of parasites. An early report described activity against a single isolate of T. vaginalis; 3 the purpose of our study was to measure the activity of disulfiram and its first mammalian metabolite, diethyldithiocarbamate (ditiocarb), against a number of metronidazole-sensitive and -resistant strains of T. vaginalis and T. foetus. 
Materials and methods

Reagents
MIC determination
MICs (doubling dilutions) were determined by the microplate method 2, 4 under both aerobic and anaerobic conditions using the medium specified complete or without cysteine and ascorbic acid. In some experiments TPS-1 medium 5 without cysteine or ascorbic acid was employed. Organisms were always grown in complete medium. In each plate triplicate rows were set up for each strain; T. vaginalis 1910 was included in each experiment. Metronidazole and diluent blanks were included in each plate. End points (defined as lack of visible motility) were assessed at 48 h using an inverted microscope. On a few occasions, cells from the end-point well were subcultured into complete, drug-free medium and incubated for 48 h; no growth was ever observed.
Results and discussion
The most consistent correlation between in-vitro MICs and clinical outcome is found when metronidazole is tested under aerobic conditions without cysteine or ascorbate in the medium;
2 direct measurement has shown that the environment in the human vagina is microaerophilic 6 and this may explain the correlation. Under these conditions both disulfiram and ditiocarb are highly active against both metronidazole-sensitive and resistant strains of both T. vaginalis and T. foetus (Table I) although MICs tend to be slightly higher with metronidazole-resistant than with -sensitive T. vaginalis. In our hands T. vaginalis ATCC 50141, described as highly metronidazole-resistant, appeared sensitive (Table I) ; it was, however, resistant when tested under aerobic conditions in complete medium (data not shown). Under anaerobic conditions in complete medium (containing both cysteine and ascorbic acid), several strains of T. vaginalis, both resistant (ATCC 50138, 50141, 50142, 50143) and sensitive to metronidazole (ATCC 50144), and most isolates of T. foetus show resistance to disulfiram and ditiocarb (Table II) . We interpret this to suggest that oxidation of both compounds may be necessary to produce an active metabolite.
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Under aerobic conditions and in the absence of reducing agents, disulfiram was always more effective (MIC six-to 20-fold lower) than ditiocarb against both species and regardless of metronidazole resistance ( Table  I) . As expected, MIC values for metronidazole were much lower under anaerobic than under aerobic conditions.
The aerobic MIC values reported here for T. vaginalis (disulfiram, 0.1-1.3 M; ditiocarb, 0.3-9 M) and T. foetus (disulfiram, 0.1-1 M; ditiocarb, 1.0-6.9 M) are considerably lower than those found for metronidazole (Table I) ; Jeney & Zsolnai, 3 working with a single isolate 
